Filing Details
- Accession Number:
- 0001209191-22-060901
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-12-13 16:12:39
- Reporting Period:
- 2022-12-12
- Accepted Time:
- 2022-12-13 16:12:39
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1492426 | Horizon Therapeutics Public Ltd Co | HZNP | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1230482 | W Jeffrey Sherman | C/O Horizon Therapeutics Plc, 70 St. Stephen?S Green Dublin L2 D02 E2X4 | Evp And Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Ordinary Shares | Disposition | 2022-05-27 | 8,531 | $0.00 | 2,375 | No | 5 | G | Direct | |
Ordinary Shares | Acquisiton | 2022-05-27 | 8,531 | $0.00 | 61,475 | No | 5 | G | Indirect | See Footnote |
Ordinary Shares | Disposition | 2022-12-12 | 6,974 | $111.44 | 54,501 | No | 4 | S | Indirect | See Footnote |
Ordinary Shares | Disposition | 2022-12-12 | 21,378 | $111.45 | 84,430 | No | 4 | S | Indirect | See footnote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 5 | G | Direct | |
No | 5 | G | Indirect | See Footnote |
No | 4 | S | Indirect | See Footnote |
No | 4 | S | Indirect | See footnote |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Ordinary Shares | 66,730 | Indirect | By Spouse |
Footnotes
- Includes 277 ordinary shares of the Issuer acquired by the reporting person on June 1, 2022 pursuant to an employee stock purchase program.
- The shares are held in the Jeffrey W. Sherman Living Trust.
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 11, 2022.
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.20 to $111.71 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.20 to $111.74 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The shares are held in the name of the Jeffrey W. Sherman 2020 Gift Trust, of which the reporting person's spouse is the Trustee.